Cargando…
Reagents and models for detecting endogenous GLP1R and GIPR
Glucagon-like peptide-1 receptor (GLP1R) agonists target the GLP1R, whereas dual GLP1R/ gastric inhibitory polypeptide receptor (GIPR) agonists target both the GLP1R and GIPR. Despite the importance of these drug classes for the treatment of diabetes and obesity, still very little is known about the...
Autores principales: | Ast, Julia, Broichhagen, Johannes, Hodson, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669301/ https://www.ncbi.nlm.nih.gov/pubmed/34911028 http://dx.doi.org/10.1016/j.ebiom.2021.103739 |
Ejemplares similares
-
Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells
por: Manchanda, Yusman, et al.
Publicado: (2023) -
Expanded LUXendin Color Palette for GLP1R Detection
and Visualization In Vitro and In Vivo
por: Ast, Julia, et al.
Publicado: (2022) -
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
por: Wang, Lijing
Publicado: (2022) -
Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
por: Morrow, Nadya M., et al.
Publicado: (2021) -
GLP1R Attenuates Sympathetic Response to High Glucose via Carotid Body Inhibition
por: Pauza, Audrys G., et al.
Publicado: (2022)